Ankhi Dutta

Summary

Publications

  1. doi request reprint Risk factors of amphotericin B toxicty in the nonneonatal pediatric population
    Ankhi Dutta
    From the Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX 77030, USA
    Pediatr Infect Dis J 31:910-4. 2012
  2. doi request reprint Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population
    Ankhi Dutta
    Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX, USA
    Pediatr Infect Dis J 30:664-8. 2011

Detail Information

Publications2

  1. doi request reprint Risk factors of amphotericin B toxicty in the nonneonatal pediatric population
    Ankhi Dutta
    From the Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX 77030, USA
    Pediatr Infect Dis J 31:910-4. 2012
    ..Amphotericin B (AmB) traditionally has been the mainstay of therapy for children with candidemia but is associated with drug-related toxicities (DRT). Studies investigating the risk factors for AmB DRT in children are limited...
  2. doi request reprint Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population
    Ankhi Dutta
    Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX, USA
    Pediatr Infect Dis J 30:664-8. 2011
    ..Non-albicans Candida (NAC) species have been implicated as major pathogens in patients with hospital-acquired candidemia. Few studies have investigated the impact of NAC fungemia among pediatric patients outside of the neonatal age group...